Original Article
Online First™Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
E. Gabriela Chiorean, Sonal Sanghani, Marissa A. Schiel, Menggang Yu and Matthew Burns, et al.
Online First™, 19 May 2012
Original Article
Online First™Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies
Muneaki Shimada, Hiroyuki Fujiwara, Shinya Sato, Tetsuro Oishi and Hiroaki Itamochi, et al.
Online First™, 19 May 2012
Original Article
Online First™Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies
Zhen-Hua Wang, Qin-Yan Gao and Jing-Yuan Fang
Online First™, 19 May 2012
Original Article
Online First™Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats
Nawale Hajjaji, Pierre Besson and Philippe Bougnoux
Online First™, 19 May 2012
Review Article
Online First™Lenalidomide in solid tumors
Angela Segler and Apostolia-Maria Tsimberidou
Online First™, 15 May 2012
Short Communication
Online First™Murine toxicology and pharmacokinetics evaluation of retinoic acid metabolism blocking agent (RAMBA), VN/12-1
Abhijit M. Godbole, Puranik Purushottamachar, Marlena S. Martin and Vincent C. O. Njar
Online First™, 13 May 2012
Original Article
Online First™FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
Alberto Zaniboni, Enrico Aitini, Sandro Barni, Daris Ferrari and Stefano Cascinu, et al.
Online First™, 11 May 2012
Original Article
Online First™RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR
Ziwei Liu, Qianying Yuan, Xuenong Zhang, Chaomei Xiong and Pingping Xue, et al.
Online First™, 8 May 2012
Original Article
Online First™Open AccessA phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)
Naoya Hida, Hiroaki Okamoto, Yuuki Misumi, Akira Sato and Mari Ishii, et al.
Online First™, 8 May 2012
Original Article
Online First™An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel
Toshitaka Uchiyama, Hitoshi Kanno, Ken Ishitani, Hisaichi Fujii and Hiroaki Ohta, et al.
Online First™, 6 May 2012